Loading...

IMMU-47. RNA-NANOPARTICLE VACCINES ARE SAFE AND IMMUNOLOGICALLY ACTIVE IN CLIENT-OWNED CANINES WITH TERMINAL GLIOMAS

BACKGROUND: The lack of appropriate preclinical murine glioblastoma models limits comprehensive toxicity/efficacy evaluation of investigational agents. To overcome this challenge, we evaluated the safety and activity of a new immunotherapeutic technology that we have pioneered (composed of tumor mRN...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Neuro Oncol
Main Authors: Carrera-Justiz, Sheila, Stover, Brian, Milner, Rowan, Weidert, Frances, Huang, Jianping, Mitchell, Duane, Mendez-Gomez, Hector, Sayour, Elias
Format: Artigo
Sprog:Inglês
Udgivet: Oxford University Press 2019
Fag:
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6847721/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noz175.539
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!